Identifying Contraindicated Antihypertensive Drugs in Pregnancy
The question asks to identify an antihypertensive drug that should not be used during pregnancy (contraindicated). Among the options provided, Ramipril is the drug that is contraindicated.
Reasoning for Ramipril Contraindication
Ramipril is an Angiotensin-Converting Enzyme (ACE) inhibitor. ACE inhibitors are known to cause fetal and neonatal toxicity, including:
- Fetal malformations (especially renal defects)
- Oligohydramnios (low amniotic fluid)
- Fetal death
- Skull hypoplasia
Due to these significant risks, ACE inhibitors like Ramipril are strictly contraindicated during pregnancy, particularly in the second and third trimesters.
Safety of Other Antihypertensive Options
The other drugs listed are generally considered safer or even commonly used in managing hypertension during pregnancy:
- Hydralazine: A vasodilator often used for hypertensive emergencies in pregnancy.
- Amlodipine: A calcium channel blocker that may be used for hypertension in pregnancy.
- Labetalol: A combined alpha- and beta-blocker frequently used as a first-line agent for hypertension in pregnancy.
Conclusion
Based on established pharmacological guidelines, Ramipril poses significant risks to the developing fetus and is therefore contraindicated in pregnancy.
Important Questions from General Clinical Conditions
- The height of the Jugular Venous Pulse is determined by :
- The SA node is situated at the junction of:
- Reverse splitting of second heart sound is most commonly seen in :
- A 70-year-old man with dyspnoea on exertion has been found to have a single second heart sound and a loud diamond-shaped, rough quality systolic murmur best heard at the right $2^{nd}$ intercostal space, radiating to the right carotid artery. Which one of the following is the likely diagnosis ?
Consider the following statements with regard to pulmonary embolism :
1. Unexplained breathlessness is the most common symptom.
2. When congestive heart failure or pneumonia fail to improve despite standard medical treatment, occult pulmonary embolism should be considered.
3. Patients with high clinical likelihood of venous thromboembolism should first undergo D-dimer testing alone without obligatory imaging tests.
Which of the statements given above are correct?
